These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

116 related articles for article (PubMed ID: 22450419)

  • 21. Health Economics as Rhetoric: The Limited Impact of Health Economics on Funding Decisions in Four European Countries.
    Franken M; Heintz E; Gerber-Grote A; Raftery J
    Value Health; 2016 Dec; 19(8):951-956. PubMed ID: 27987645
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Conducting systematic reviews of economic evaluations.
    Gomersall JS; Jadotte YT; Xue Y; Lockwood S; Riddle D; Preda A
    Int J Evid Based Healthc; 2015 Sep; 13(3):170-8. PubMed ID: 26288063
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Consolidated Health Economic Evaluation Reporting Standards (CHEERS)--explanation and elaboration: a report of the ISPOR Health Economic Evaluation Publication Guidelines Good Reporting Practices Task Force.
    Husereau D; Drummond M; Petrou S; Carswell C; Moher D; Greenberg D; Augustovski F; Briggs AH; Mauskopf J; Loder E;
    Value Health; 2013; 16(2):231-50. PubMed ID: 23538175
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Use of economic evaluation in local health care decision-making in England: a qualitative investigation.
    Eddama O; Coast J
    Health Policy; 2009 Mar; 89(3):261-70. PubMed ID: 18657336
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Transferring the burden of risk in private health care: medical indemnity insurance reform.
    Patterson RM
    J Law Med; 2003 Nov; 11(2):214-29. PubMed ID: 14655585
    [TBL] [Abstract][Full Text] [Related]  

  • 26. [IQWiG's methods for the cost-benefit assessment : Comparison with an international reference scenario].
    Schwalm A; Danner M; Seidl A; Volz F; Dintsios CM; Gerber A
    Bundesgesundheitsblatt Gesundheitsforschung Gesundheitsschutz; 2010 Jun; 53(6):615-22. PubMed ID: 20449550
    [TBL] [Abstract][Full Text] [Related]  

  • 27. The efficiency-frontier approach for health economic evaluation versus cost-effectiveness thresholds and internal reference pricing: combining the best of both worlds?
    Sandmann FG; Mostardt S; Lhachimi SK; Gerber-Grote A
    Expert Rev Pharmacoecon Outcomes Res; 2018 Oct; 18(5):475-486. PubMed ID: 29979895
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Systematic Review and Quality Appraisal of Economic Evaluation Publications in Dentistry.
    Tonmukayakul U; Calache H; Clark R; Wasiak J; Faggion CM
    J Dent Res; 2015 Oct; 94(10):1348-54. PubMed ID: 26082388
    [TBL] [Abstract][Full Text] [Related]  

  • 29. [Can studies on health economics be done without any requirements?].
    Lindgren B; Jacobson L
    Lakartidningen; 1995 Mar; 92(11):1067-8. PubMed ID: 7700104
    [No Abstract]   [Full Text] [Related]  

  • 30. [HEALTH ECONOMIC ANALYSIS AND FAIR DECISION MAKING].
    Jeantet M; Lopez A
    Rev Prat; 2015 Sep; 65(7):909-11. PubMed ID: 26619723
    [TBL] [Abstract][Full Text] [Related]  

  • 31. 'Health Economics' and the evolution of economic evaluation of health technologies.
    Hutton J
    Health Econ; 2012 Jan; 21(1):13-8. PubMed ID: 22147623
    [No Abstract]   [Full Text] [Related]  

  • 32. Introduction to clinical economics: assessment of cancer therapies.
    Schulman KA; Glick HA; Yabroff KR; Eisenberg JM
    J Natl Cancer Inst Monogr; 1995; (19):1-9. PubMed ID: 7577196
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Monitoring and evaluating managed care for children with chronic illnesses and disabilities.
    Newacheck PW; Stein RE; Walker DK; Gortmaker SL; Kuhlthau K; Perrin JM
    Pediatrics; 1996 Nov; 98(5):952-8. PubMed ID: 8909492
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Economic evaluation of integrated new technologies for health and social care: Suggestions for policy makers, users and evaluators.
    Wildman J; McMeekin P; Grieve E; Briggs A
    Soc Sci Med; 2016 Nov; 169():141-148. PubMed ID: 27721138
    [TBL] [Abstract][Full Text] [Related]  

  • 35. [Analysis of economic data and elaboration of professional guidelines].
    Charvet-Protat S; Thoral F
    Gastroenterol Clin Biol; 1999 Jan; 23(1):19-23. PubMed ID: 10219600
    [TBL] [Abstract][Full Text] [Related]  

  • 36. A reader's guide to economic analysis in the GI literature.
    Provenzale D; Lipscomb J
    Am J Gastroenterol; 1996 Dec; 91(12):2461-70. PubMed ID: 8946967
    [TBL] [Abstract][Full Text] [Related]  

  • 37. A Systematic Review of Health Economic Evaluation Studies Using the Patient's Perspective.
    Tai BB; Bae YH; Le QA
    Value Health; 2016; 19(6):903-908. PubMed ID: 27712720
    [TBL] [Abstract][Full Text] [Related]  

  • 38. [Costs and benefits in health care--in search of a correct assessment].
    Selbmann HK
    Dtsch Med Wochenschr; 2008 Dec; 133(49):2579-81. PubMed ID: 19039714
    [No Abstract]   [Full Text] [Related]  

  • 39. Quality assessment of economic evaluations in selected pharmacy, medical, and health economics journals.
    Bradley CA; Iskedjian M; Lanctôt KL; Mittmann N; Simone C; St Pierre E; Miller E; Blatman B; Chabursky B; Einarson TR
    Ann Pharmacother; 1995; 29(7-8):681-9. PubMed ID: 8520080
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Systematic reviews of health economic evaluations: a protocol for a systematic review of characteristics and methods applied.
    Luhnen M; Prediger B; Neugebauer EAM; Mathes T
    Syst Rev; 2017 Dec; 6(1):238. PubMed ID: 29197411
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.